News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
658,909 Results
Type
Article (48275)
Company Profile (395)
Press Release (610239)
Multimedia
Podcasts (95)
Webinars (12)
Section
Business (179711)
Career Advice (3128)
Deals (32496)
Drug Delivery (105)
Drug Development (80399)
Employer Resources (176)
FDA (15469)
Job Trends (13747)
News (314426)
Policy (30040)
Tag
Academia (2735)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (88)
Alliances (45927)
ALS (94)
Alzheimer's disease (1446)
Antibody-drug conjugate (ADC) (143)
Approvals (15441)
Artificial intelligence (263)
Autoimmune disease (27)
Automation (14)
Bankruptcy (308)
Best Places to Work (11153)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (307)
Bladder cancer (84)
Brain cancer (31)
Breast cancer (290)
Cancer (2338)
Cardiovascular disease (188)
Career advice (2640)
Career pathing (33)
CAR-T (173)
Cell therapy (483)
Cervical cancer (19)
Clinical research (65235)
Collaboration (866)
Company closure (1)
Compensation (521)
Complete response letters (27)
COVID-19 (2548)
CRISPR (47)
C-suite (252)
Cystic fibrosis (106)
Data (2225)
Decentralized trials (2)
Denatured (28)
Depression (51)
Diabetes (280)
Diagnostics (5893)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (43)
Drug discovery (128)
Drug pricing (107)
Drug shortages (31)
Duchenne muscular dystrophy (101)
Earnings (70986)
Editorial (45)
Employer branding (22)
Employer resources (153)
Events (111404)
Executive appointments (714)
FDA (16726)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (771)
Gene editing (115)
Generative AI (24)
Gene therapy (355)
GLP-1 (764)
Government (4352)
Grass and pollen (5)
Guidances (60)
Healthcare (18446)
Huntington's disease (23)
IgA nephropathy (30)
Immunology and inflammation (137)
Indications (30)
Infectious disease (2682)
Inflammatory bowel disease (149)
Inflation Reduction Act (11)
Influenza (48)
Intellectual property (100)
Interviews (608)
IPO (15538)
IRA (43)
Job creations (3041)
Job search strategy (2164)
Kidney cancer (10)
Labor market (36)
Layoffs (459)
Leadership (23)
Legal (6726)
Liver cancer (75)
Lung cancer (326)
Lymphoma (154)
Machine learning (7)
Management (62)
Manufacturing (320)
MASH (73)
Medical device (12334)
Medtech (12338)
Mergers & acquisitions (17539)
Metabolic disorders (734)
Multiple sclerosis (80)
NASH (22)
Neurodegenerative disease (103)
Neuropsychiatric disorders (33)
Neuroscience (2016)
NextGen: Class of 2025 (6452)
Non-profit (4392)
Now hiring (31)
Obesity (393)
Opinion (263)
Ovarian cancer (76)
Pain (97)
Pancreatic cancer (78)
Parkinson's disease (155)
Partnered (21)
Patents (232)
Patient recruitment (111)
Peanut (48)
People (52581)
Pharmaceutical (76)
Pharmacy benefit managers (20)
Phase I (20459)
Phase II (28819)
Phase III (21548)
Pipeline (1216)
Policy (151)
Postmarket research (2403)
Preclinical (8675)
Press Release (72)
Prostate cancer (112)
Psychedelics (37)
Radiopharmaceuticals (265)
Rare diseases (420)
Real estate (5375)
Recruiting (70)
Regulatory (21101)
Reports (35)
Research institute (2387)
Resumes & cover letters (502)
Rett syndrome (5)
RNA editing (5)
RSV (39)
Schizophrenia (78)
Series A (132)
Series B (88)
Service/supplier (9)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (154)
Sponsored (33)
Startups (3360)
State (2)
Stomach cancer (16)
Supply chain (68)
Tariffs (39)
The Weekly (66)
Vaccines (671)
Venture capitalists (42)
Weight loss (272)
Women's health (31)
Worklife (20)
Date
Today (33)
Last 7 days (896)
Last 30 days (2556)
Last 365 days (32928)
2025 (10894)
2024 (35341)
2023 (39803)
2022 (50523)
2021 (54809)
2020 (52577)
2019 (45156)
2018 (34179)
2017 (31796)
2016 (31308)
2015 (36389)
2014 (28868)
2013 (23700)
2012 (24927)
2011 (25693)
2010 (23830)
Location
Africa (870)
Alabama (54)
Alaska (6)
Arizona (184)
Arkansas (14)
Asia (37968)
Australia (6564)
California (6065)
Canada (1977)
China (530)
Colorado (257)
Connecticut (273)
Delaware (148)
Europe (87628)
Florida (886)
Georgia (200)
Idaho (52)
Illinois (544)
India (26)
Indiana (282)
Iowa (10)
Japan (162)
Kansas (99)
Kentucky (24)
Louisiana (11)
Maine (59)
Maryland (845)
Massachusetts (4727)
Michigan (229)
Minnesota (382)
Mississippi (2)
Missouri (86)
Montana (27)
Nebraska (24)
Nevada (55)
New Hampshire (61)
New Jersey (1703)
New Mexico (29)
New York (1715)
North Carolina (1022)
North Dakota (8)
Northern California (2638)
Ohio (200)
Oklahoma (14)
Oregon (34)
Pennsylvania (1365)
Puerto Rico (11)
Rhode Island (33)
South America (1168)
South Carolina (21)
Southern California (2267)
Tennessee (88)
Texas (876)
United States (22985)
Utah (166)
Virginia (147)
Washington D.C. (58)
Washington State (571)
West Virginia (3)
Wisconsin (51)
658,909 Results for "the ritedose corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand for Ophthalmic and Respiratory Medications
The Ritedose Corporation, the leading contract development and manufacturing organization specializing in sterile Blow Fill Seal production, announces a significant expansion of its production capabilities to meet the demand for ophthalmic and respiratory medications.
June 20, 2024
·
3 min read
Press Releases
United Therapeutics Corporation Reports First Quarter 2025 Financial Results
April 30, 2025
·
11 min read
Press Releases
Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update
April 30, 2025
·
8 min read
Press Releases
Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
May 2, 2025
·
19 min read
Press Releases
CARGO Therapeutics Provides Corporate Update
March 18, 2025
·
4 min read
Press Releases
Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update
April 10, 2025
·
2 min read
Press Releases
Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025
April 28, 2025
·
1 min read
Press Releases
CORCEPT THERAPEUTICS TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALL
April 28, 2025
·
1 min read
Press Releases
LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025
April 30, 2025
·
1 min read
Press Releases
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025
April 23, 2025
·
1 min read
1 of 65,891
Next
